140 related articles for article (PubMed ID: 38362598)
1. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.
Makino K; Ishii T; Takeda H; Saito Y; Fujiwara Y; Fujimoto M; Ito T; Wakama S; Kumagai K; Munekage F; Horie H; Tomofuji K; Oshima Y; Uebayashi EY; Kawai T; Ogiso S; Fukumitsu K; Takai A; Seno H; Hatano E
J Pathol; 2024 May; 263(1):32-46. PubMed ID: 38362598
[TBL] [Abstract][Full Text] [Related]
2. Diversity in cell differentiation, histology, phenotype and vasculature of mass-forming intrahepatic cholangiocarcinomas.
Nguyen Canh H; Takahashi K; Yamamura M; Li Z; Sato Y; Yoshimura K; Kozaka K; Tanaka M; Nakanuma Y; Harada K
Histopathology; 2021 Nov; 79(5):731-750. PubMed ID: 34018212
[TBL] [Abstract][Full Text] [Related]
3. Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma.
Kusano H; Naito Y; Mihara Y; Kondo R; Ogasawara S; Akiba J; Nakashima O; Yano H
Hepatol Res; 2020 Jan; 50(1):84-91. PubMed ID: 31733634
[TBL] [Abstract][Full Text] [Related]
4. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
[TBL] [Abstract][Full Text] [Related]
5. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing.
Craig AJ; Silveira MAD; Ma L; Revsine M; Wang L; Heinrich S; Rae Z; Ruchinskas A; Dadkhah K; Do W; Behrens S; Mehrabadi FR; Dominguez DA; Forgues M; Budhu A; Chaisaingmongkol J; Hernandez JM; Davis JL; Tran B; Marquardt JU; Ruchirawat M; Kelly M; Greten TF; Wang XW
Cell Rep; 2023 Nov; 42(11):113446. PubMed ID: 37980571
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Immunogenomic Profiling of
Makawita S; Lee S; Kong E; Kwong LN; Abouelfetouh Z; Danner De Armas A; Xiao L; Murugesan K; Danziger N; Pavlick D; Korkut A; Ross JS; Javle M
JCO Precis Oncol; 2024 Mar; 8():e2300544. PubMed ID: 38547421
[TBL] [Abstract][Full Text] [Related]
8. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
Xu J; Zhang C; Qiao A; Xi Y
Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of cholangiolocarcinoma and impact of tumor heterogeneity on prognosis: A single institution retrospective study.
Sugita H; Nakanuma S; Gabata R; Tokoro T; Takei R; Okazaki M; Kato K; Takada S; Makino I; Kozaka K; Harada K; Yagi S
Oncol Lett; 2024 May; 27(5):213. PubMed ID: 38572060
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma.
Kinzler MN; Schulze F; Jeroch J; Schmitt C; Ebner S; Gretser S; Bein J; Finkelmeier F; Trojan J; Zeuzem S; Schnitzbauer AA; Demes MC; Reis H; Wild PJ; Walter D
Histopathology; 2024 May; 84(6):1061-1067. PubMed ID: 38409827
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
[TBL] [Abstract][Full Text] [Related]
12. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2022 Apr; 80(5):859-868. PubMed ID: 35076959
[TBL] [Abstract][Full Text] [Related]
13. Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological study.
Sasaki M; Sato Y; Nakanuma Y
Virchows Arch; 2024 Mar; ():. PubMed ID: 38532197
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma.
Balitzer D; Joseph NM; Ferrell L; Shafizadeh N; Jain D; Zhang X; Yeh M; di Tommaso L; Kakar S
Mod Pathol; 2019 Oct; 32(10):1486-1494. PubMed ID: 31186529
[TBL] [Abstract][Full Text] [Related]
15. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
[No Abstract] [Full Text] [Related]
16. Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.
Chung T; Park YN
Front Med (Lausanne); 2022; 9():857140. PubMed ID: 35433771
[TBL] [Abstract][Full Text] [Related]
17. Synchronous Double Primary Combined Hepatocellular-cholangiocarcinoma and Cholangiolocarcinoma in a Cirrhotic Liver.
Sakata M; Kitada K; Omote R; Sonobe H; Utsumi M; Tokunaga N; Fushimi T; Nagao R; Sakata T; Kaneyoshi T; Toyokawa T; Inagaki M
J Clin Transl Hepatol; 2023 Aug; 11(4):991-997. PubMed ID: 37408806
[TBL] [Abstract][Full Text] [Related]
18. Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version).
Wang H; Chen J; Zhang X; Sheng X; Chang XY; Chen J; Chen MS; Dong H; Duan GJ; Hu HP; Huang ZY; Jia WD; Jiang XQ; Kuang D; Li SS; Li ZS; Lu CL; Qin SK; Qiu XS; Qu LJ; Shao CK; Shen F; Shi GM; Shi SS; Shi YJ; Sun HC; Teng XD; Wang B; Wang ZB; Wen TF; Yang JM; Yang QQ; Ye SL; Yin HF; Yuan ZG; Yun JP; Zang FL; Zhang HQ; Zhang LH; Zhao JM; Zhou J; Zhou WX; Fan J; Chen XP; Lau WY; Ji Y; Cong WM;
J Clin Transl Hepatol; 2023 Dec; 11(7):1553-1564. PubMed ID: 38161496
[TBL] [Abstract][Full Text] [Related]
19. Cholangiolocellular Carcinoma With "Ductal Plate Malformation" Pattern May Be Characterized by ARID1A Genetic Alterations.
Sasaki M; Sato Y; Nakanuma Y
Am J Surg Pathol; 2019 Mar; 43(3):352-360. PubMed ID: 30520820
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic study on cholangiolocellular carcinoma.
Shiota K; Taguchi J; Nakashima O; Nakashima M; Kojiro M
Oncol Rep; 2001; 8(2):263-8. PubMed ID: 11182037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
